Combination of serum microRNA-320a and microRNA-320b as a marker for Waldenström macroglobulinemia

American Journal of Hematology

Volumn 90, Issue 3, 2015, Pages E51-E52

  Kubiczkova Besse, Lenka ^a,b   Sedlarikova, Lenka ^a,b   Kryukov, Fedor ^a,c   Nekvindova, Jana ^d   Radova, Lenka ^a   Almasi, Martina ^a,b   Pelcova, Jana ^b   Minarik, Jiri ^e   Pika, Tomas ^e   Pikalova, Zuzana ^e   Scudla, Vlastimil ^e   Krejci, Marta ^b   Adam, Zdenek ^b   Pour, Ludek ^b   Hajek, Roman ^a,b,c   Sevcikova, Sabina ^a,b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^c UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^d UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^e UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE; MICRORNA; MICRORNA 320A; MICRORNA 320B; MYELOID DIFFERENTIATION FACTOR 88; UNCLASSIFIED DRUG; MIRN320 MICRORNA, HUMAN; TUMOR MARKER;

ARTICLE; BONE MARROW BIOPSY; DISEASE COURSE; EXOSOME; FLOW CYTOMETRY; HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; WALDENSTROEM MACROGLOBULINEMIA; BLOOD; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION REGULATION; GENETICS; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; WALDENSTROM MACROGLOBULINEMIA;

BIOMARKERS, TUMOR; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULIN M; MICRORNAS; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; ROC CURVE; WALDENSTROM MACROGLOBULINEMIA;

EID: 84923103534     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23910     Document Type: Article

References (8)

1. Kyle RA. Sequence of testing for monoclonal gammopathies. Arch Pathol Lab Med 1999;123:114-118.
2. Kyle RA, Garton JP. The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clin Proc 1987;62:719-731.
3. Ansell SM, Kyle RA, Reeder CB, et al. Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines. Mayo Clin Proc 2010;85:824-833.
4. Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 2009;23:3-9.
5. Treon SP, Xu L, Yang G, et al. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. N Engl J Med 2012;367:826-833.
6. Roccaro AM, Sacco A, Jimenez C, et al. C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma. Blood 2014;123:4120-4131.
7. Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008;3:e3148.
8. Kubiczkova L, Kryukov F, Slaby O, et al. Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance. Haematologica 2014;99:511-518.